 Inhibition cell cytotoxicity sulphasalazine effect vivo treatment acid sulphasalazine vitro natural killer cell activity cell cytotoxicity inflammatory bowel disease patients active disease clear decrease disease consequence medical treatment study effect vivo treatment acid sulphasalazine vitro natural killer cell activity patients inflammatory bowel disease remission healthy control double blind trial weeks treatment placebo natural killer cell activity subjects weeks sulphasalazine treatment subjects slow acetylator phenotype contrast acid treatment marginal reaction natural killer cell activity subjects inhibitory effects reversible decreased natural killer cell activity placebo treatment subjects conclusion vivo treatment sulphasalazine inhibits vitro natural killer cell activity sulphapyridine moiety phenomenon low natural killer cell activity patients active inflammatory bowel disease